Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.23 Million ≈ $-1.06 Million USD) by net assets (CN¥2.30 Billion ≈ $336.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Tonghua Golden-Horse Pharmaceutical Indu balance sheet liabilities for a breakdown of total debt and financial obligations.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jason Furniture(Hangzhou)
SHG:603816
0.072x
Godrej Industries Limited
NSE:GODREJIND
-0.185x
CIE Automotive S.A.
MC:CIE
0.329x
Seek Ltd
AU:SEK
0.064x
Jiangsu Aucksun Co Ltd
SHE:002245
0.038x
Signet Jewelers Ltd
NYSE:SIG
0.018x
CommVault Systems Inc
NASDAQ:CVLT
0.019x
Pony AI Inc. American Depositary Shares
NASDAQ:PONY
-0.070x

Annual Cash Flow Conversion Efficiency for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Tonghua Golden-Horse Pharmaceutical Indu worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.26 Billion
≈ $330.04 Million
CN¥162.75 Million
≈ $23.81 Million
0.072x +48.32%
2023-12-31 CN¥2.32 Billion
≈ $339.21 Million
CN¥112.78 Million
≈ $16.50 Million
0.049x -41.85%
2022-12-31 CN¥2.37 Billion
≈ $346.59 Million
CN¥198.16 Million
≈ $29.00 Million
0.084x +41.49%
2021-12-31 CN¥2.34 Billion
≈ $342.31 Million
CN¥138.33 Million
≈ $20.24 Million
0.059x +68.91%
2020-12-31 CN¥2.31 Billion
≈ $337.34 Million
CN¥80.71 Million
≈ $11.81 Million
0.035x +24.67%
2019-12-31 CN¥2.67 Billion
≈ $390.12 Million
CN¥74.86 Million
≈ $10.95 Million
0.028x -22.55%
2018-12-31 CN¥4.71 Billion
≈ $689.06 Million
CN¥170.72 Million
≈ $24.98 Million
0.036x +506.01%
2017-12-31 CN¥4.42 Billion
≈ $646.57 Million
CN¥26.43 Million
≈ $3.87 Million
0.006x -72.53%
2016-12-31 CN¥4.16 Billion
≈ $608.95 Million
CN¥90.63 Million
≈ $13.26 Million
0.022x +130.40%
2015-12-31 CN¥2.25 Billion
≈ $328.72 Million
CN¥-160.95 Million
≈ $-23.55 Million
-0.072x -237.69%
2014-12-31 CN¥659.50 Million
≈ $96.51 Million
CN¥34.32 Million
≈ $5.02 Million
0.052x -68.91%
2013-12-31 CN¥615.08 Million
≈ $90.01 Million
CN¥102.96 Million
≈ $15.07 Million
0.167x +1697.12%
2012-12-31 CN¥619.60 Million
≈ $90.67 Million
CN¥-6.49 Million
≈ $-950.31K
-0.010x +19.78%
2011-12-31 CN¥607.13 Million
≈ $88.84 Million
CN¥-7.93 Million
≈ $-1.16 Million
-0.013x -126.80%
2010-12-31 CN¥595.89 Million
≈ $87.20 Million
CN¥29.05 Million
≈ $4.25 Million
0.049x -64.39%
2009-12-31 CN¥583.87 Million
≈ $85.44 Million
CN¥79.94 Million
≈ $11.70 Million
0.137x +639.34%
2008-12-31 CN¥554.08 Million
≈ $81.08 Million
CN¥10.26 Million
≈ $1.50 Million
0.019x -0.09%
2007-12-31 CN¥536.90 Million
≈ $78.57 Million
CN¥9.95 Million
≈ $1.46 Million
0.019x +153.30%
2006-12-31 CN¥518.07 Million
≈ $75.81 Million
CN¥-18.02 Million
≈ $-2.64 Million
-0.035x -104.40%
2005-12-31 CN¥45.26 Million
≈ $6.62 Million
CN¥35.74 Million
≈ $5.23 Million
0.790x +51.26%
2004-12-31 CN¥36.64 Million
≈ $5.36 Million
CN¥19.12 Million
≈ $2.80 Million
0.522x +68.00%
2003-12-31 CN¥296.07 Million
≈ $43.32 Million
CN¥91.99 Million
≈ $13.46 Million
0.311x +109.74%
2002-12-31 CN¥490.79 Million
≈ $71.82 Million
CN¥72.70 Million
≈ $10.64 Million
0.148x +109.51%
2001-12-31 CN¥475.05 Million
≈ $69.52 Million
CN¥-740.34 Million
≈ $-108.34 Million
-1.558x -955.58%
2000-12-31 CN¥1.08 Billion
≈ $157.58 Million
CN¥196.15 Million
≈ $28.70 Million
0.182x +336.55%
1999-12-31 CN¥1.05 Billion
≈ $153.20 Million
CN¥-80.62 Million
≈ $-11.80 Million
-0.077x +22.07%
1998-12-31 CN¥636.82 Million
≈ $93.19 Million
CN¥-62.93 Million
≈ $-9.21 Million
-0.099x --

About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

SHE:000766 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.49 Billion
CN¥23.84 Billion CNY
Market Cap Rank
#4506 Global
#808 in China
Share Price
CN¥24.67
Change (1 day)
+3.14%
52-Week Range
CN¥17.40 - CN¥29.50
All Time High
CN¥29.50
About

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides… Read more